NCT03073239View on ClinicalTrials.gov

Amyotrophic Lateral Sclerosis: a New Paradigm

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

June 30, 2018

Conditions
Amyotrophic Lateral Sclerosis
Interventions
GENETIC

ALS patients genetic characterization

Genetic findings in ALS patients

OTHER

ALS patients epidemiological caracterization

Epidemiological characterization in ALS patients

Trial Locations (1)

5000

Centro Hospitalar Tras-os-Montes e Alto Douro, Vila Real

All Listed Sponsors
lead

Conde, Bebiana, M.D.

INDIV

NCT03073239 - Amyotrophic Lateral Sclerosis: a New Paradigm | Biotech Hunter | Biotech Hunter